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Though several procedures of IOL implantation have been described (sutured scleral fixa-
tion, intra-scleral fixation, angle-supported anterior chamber, and anterior chamber or retro-
pupillary iris-claw IOLs), there are no randomized trials which are comparing different
techniques. Hence, the surgical treatment of aphakia still remains controversial and chal-
lenging. The purpose of this study was to compare the long-term efficacy and the rate of
complications of anterior versus posterior Iris-claw intraocular lenses (IOL) implantation to
correct for the treatment of aphakia without sufficient capsule support.
Methods and findings
Consecutive eyes having secondary implantation of aphakic iris-fixated IOLs with a follow-
up of at least 5 years were considered. Mean correct distance visual acuity (CDVA)
changes, percentage of eyes with CDVA improvement, mean corneal endothelial cell den-
sity (CECD) loss and the rate of other complications were used for statistical analysis. The
study evaluated a total of 180 eyes (Group A: 87 anterior chamber iris-claw fixation, Group
B: 93 retropupillary iris-claw implantation) of 180 consecutive different patients, with aphakia
of various reasons. CDVA improved significantly in both groups after surgery (P<0.001,
ANOVA), and was remarkably higher than baseline in both groups from first week and dur-
ing the entire follow-up (P<0.001, Tukey’s Honest Significant Difference). There was no sta-
tistically significant difference in CDVA between the two groups during each follow-up visits
(P = NS, unpaired t-test) and in the CDVA improvement percentage between the two groups
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(P = 0.882, Chi-square test). No significant changes in CECD were noted after surgery in
both groups (ANOVA Group A: P = 0.067, Group B: P = 0.330P). No intra-operative compli-
cations occurred in both groups. There was no statistically significant difference in the rate
of complications between the two groups (P = NS, Chi-square test), except for pigment pre-
cipitates which were higher in Group A (P<0.05, Chi-square test).
Conclusions
Five-year follow-up shows that secondary implantation of aphakic IOLs is effective and safe
for the correction treatment of aphakia in eyes without capsule support.
Introduction
Aphakia, with an inadequate capsular support for in-the-bag or sulcus intraocular lens (IOL)
implantation in the bag or ciliary sulcus, may be the result of complicated cataract surgery,
lens dislocation or trauma [1]. Nowadays, the surgical treatment is controversial and remains
a challenge. Though several procedures of IOL implantation have been described (sutured
scleral fixation, intra-scleral fixation, angle-supported anterior chamber, and anterior chamber
or retropupillary iris-claw IOLs) [1–3], there are no randomized trials which are comparing
different techniques. Hence, the optimal choice for an IOL implant is frequently focused on
the eye’s status and surgeon’s experience [4].
Several complications have been reported about each of these secondary implants in previ-
ous studies. The most common complication of angle-supported anterior chamber IOLs was
bullous keratopathy, followed by lens dislocation, secondary glaucoma, macular edema and
retinal detachment [5]. Scleral-sutured IOLs offer the advantage of fixation in the posterior
chamber, but the surgical technique is technically more difficult and requires a longer surgical
time. Inadequate fixation of the scleral sutures can be associated with lens tilt, suprachoroidal
and vitreous hemorrhage, or retinal detachment. Moreover, erosion of conjunctiva with expo-
sition of the fixation suture may be associated with an increased risk of endophthalmitis, and
the breaking of the suture can lead to IOL dislocation [6].
For these reasons, iris-claw aphakic IOLs are actually considered as the best choice for sec-
ondary implantation in adult patients by many surgeons. In the early 1960s, Collar implanted
the first iris-fixated lens after an intra-capsular cataract extraction, but in 1971, Worst came in
with the Iris Claw lens, and its modification evolved in the Artisan lens [4,7]. Actually iris-claw
IOL implantation is considered as an effective, predictable and safe option for aphakic eyes
without capsule support, with a quicker visual recovery, better better visual outcomes and
fewer complications than the other secondary implants. Furthermore, its placement can be
performed with a lower invasiveness and in a shorter surgical time than the others [8–10]. Iris
claw IOLs have been successfully implanted either in the anterior or in the posterior chamber
[2]. However there is no general consensus about the best placement.
To date, only one prospective study have compared the anterior and posterior secondary iris
claw fixation, but this trial involved a relatively small-size sample for a short follow-up; and also
no data have been reported on the corneal endothelial cell density (CECD) and the long-term
incidence of complications. So far, that study has not resolved safety-related problems [10].
The aim of our study was to compare the long-term efficacy and the rate of complications
of anterior and posterior Iris IOL implantation for the treatment of aphakia without sufficient
capsule support.
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Methods
Patients and methods
In this retrospective study, we have included all consecutive aphakic eyes without capsular sup-
port and who received Artisan iris-claw IOL (Ophtec BV, Groningen, The Netherlands) as sec-
ondary IOL implantation at the Department of Ophthalmology, University of Catania (Italy)
from February 5, 2008, to February 5, 2013.
The study protocol, was approved by the Local Ethics Committee of the Azienda Policlinico
Vittorio Emanuele Rodolico, Catania, Italy, confirmed the tenets of the Declaration of Hel-
sinki. A written informed consent form for the processing of personal data was obtained from
all patients.
Inclusion criteria. Aphakia which was due to trauma, complicated cataract surgery and
lens/IOL luxation, integrity of the iris which allows to enclavation of the IOL’s claw, anterior
chamber depth >3.2 mm, endothelial cell density >900/mm2, intraocular pressure (IOP)� 21
mmHg, normal retinal examination and a follow-up of at least 5 years after the surgical
procedure.
Exclusion criteria. Iris defects, glaucoma, uveitis, retinopaties and any ocular co-morbid-
ity that was judged to interfere with the improvement in visual acuity.
If both eyes of the same patient had undergone iris-claw IOL implantation, only 1 was ran-
domly selected for inclusion.
All enrolled eyes were divided into 2 groups: anterior chamber (Group A) and retropupil-
lary (Group B) implantation group. Group A received Artisan iris-claw IOL (Ophtec BV, Gro-
ningen, The Netherlands) implantation over the iris, and Group B also received same Artisan
iris-claw IOL in a face down retropupillary implantation.
Patient demographics (such as age, gender, and etiology of aphakia) and ophthalmic preop-
erative and postoperative data were abstracted from the electronic medical records. Two sepa-
rate abstractors (who had been trained in the methods of chart abstraction) reviewed the
charts of patients independently. Definitions for key variables and all data abstraction forms
were reviewed. Chart abstractors were masked to the study hypothesis.
Corrected distance visual acuity (CDVA), slit-lamp biomicroscopy examination, gonio-
scopy, IOP, central corneal thickness (CCT), corneal endothelial cell density (CECD), central
macular thickness (CMT) and fundus examination were evaluated preoperatively and after 1st
week, 1st, 3rd and 6th month, 1st, 3rd, and 5th year postoperatively.
The CDVA was measured using the Snellen chart and was converted to a logarithm of the
minimum angle of resolution (logMAR) visual acuity for calculation. Each line on the chart
represents a change of 0.1 log unit in the acuity level with a value of 0.02 log unit for each letter.
A change of at least 0.1 log units (� 5 letters) was considered statistically significant. A CDVA
of 20/2000 and 20/20000 were considered equivalent to counting fingers and hand motion at 2
feet, respectively.
IOP was measured using a Goldmann applanation tonometry. After surgery, a value of IOP
>21 mmHg was considered eligible for topical treatment with hypotensive drugs. Preoperative
anterior chamber depth and intraocular IOL position at 1st month after the surgery were
assessed with ultrasound bio-microscopy (UBM, ParadigmMedicalIndustries, Salt Lake City,
Utah). The CCT was assessed with Orbscan II (Bausch & Lomb, Inc., Rochester, New York,
USA). All examinations were performed by the experienced operators based on a manufac-
turer-recommended acquisition protocol. Proper care was taken to obtain a good centred and
aligned scan. For each eye, at least three valid assessments with wide corneal coverage were
obtained: the measurement with the least eyelid shadow was chosen for the analysis. Patients
wearing contact lenses were advised to stop their use respectively 2 weeks or 4 weeks before
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the IOL implantation. The CECD were measured by Corneal Confocal Microscope (Confos-
can 4.0, Nidek Technologies, Italy) during each visit. By semi-automated technique, automatic
cell outlines were reviewed and then corrected manually. In each eye, measurement of CECD
was made in two endothelium images and the mean value was used for data analysis. The
CMT was measured by Stratus OCT (OCT3; Zeiss-Humphrey, San Leandro, CA, USA). All
the intra-operative and postoperative complications were noted.
Surgical technique. The Artisan aphakia IOL (Ophtec BV, Groningen, The Netherlands)
having polymethyl methacrylate IOL with 8.5-mm length, 1.04 mm maximum height, and
5.4-mm optical zone width was used as the lens. The optic power was calculated using the
SRK/T formula with the aim of achieving emmetropia. IOL power as per manufacturer’s rec-
ommendation was calculated with an A-constant of 115.0 for Group A and 116.5 for Group B,
by ultrasonic biometry (QUANTEL CINESCAN S -A/B SCAN, Cournon d’Auvergne Cedex,
France). All surgeries were performed by the same surgeon under the peribulbar or subtenon
anesthesia.
Two side-ports were made at 3 and 9 o’clock positions. Anterior vitrectomy was performed
wherever it was required. Miosis was achieved by injecting intra-cameral acetylcholine 1%,
subsequently cohesive viscoelastic was injected. Superior limbal corneal incision of 5.5 mm
was designed and the Artisan IOL with the vault facing up for the anterior clawed lens, and
vault facing down for the retropupillary lens was introduced into the anterior chamber. The
IOL was rotated such that the haptics were positioned at 3 and 9 o’clock. Thereafter, Artisan
IOL’s optic was held with its special Artisan lens forceps; for anterior chamber group, iris was
enclavated at mid-periphery between claw haptics using special enclavation micro spatula. In
contrast, for the retropupillary fixation, after repositioning of one haptic, the IOL behind the
iris was enclavated using the micro spatula, followed by enclavation of the other haptic. Wher-
ever pupil was minimally distorted (i.e. ovalisation of the pupil), light diathermy application
was performed to the anterior iris tissue for contraction of tissue. This technique was aimed at
achieving immediate post-operative circular pupil. Superior peripheral iridectomy was per-
formed for only those with anterior iris claw IOL implantation. At the end of this procedure
the corneal incision is apposed with interrupted 10–0 non-absorbable nylon sutures. Visco-
elastic material was aspirated, and sub-conjunctival gentamicin and dexamethasone were
injected. Sutures were removed approximately after 2 months. All the patients were prescribed
to prednisolone acetate in tapering fashion and moxifloxacin drop 5 times/day for a week.
Statistical analysis. The values of CDVA, IOP, CCT, CECD and CMT were expressed as
mean ± standard deviation (SD). In each group, CDVA, IOP, CCT, CECD and CMT mean
values were determined before and after IOL implant by ANOVA based comparison; if signifi-
cant, the difference vs. baseline value was tested by Tukey HSD (Honest Significant Differ-
ences) test. Unpaired t-test was used to compare the values of the various parameters detected
in both the groups at each time point. Comparison of indications and complications were ana-
lyzed with Chi-square test. Statistical significance was set at P<0.05. All the data were analyzed
using the Statistical Package for the Social Sciences (SPSS), v.17.0 for Windows (SPSS, Chi-
cago, Ill., USA).
Results
Overall 180 aphakic eyes (Group A: 87 anterior chamber iris-claw fixation, Group B: 93 retro-
pupillary iris-claw implantation) of 180 patients (102 males, 78 females) met the inclusion cri-
teria and were enrolled in the study. Mean age of the patients was 70 ± 6 years (range: 51–85
years). The demographics and etiology of aphakia in both groups are summarized in Table 1.
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The most common etiologic factor was complicated cataract surgery (48% for Group A and
51% for Group B).There was no significant difference in indications in two groups (P = NS,
Chi-square test).
CDVA
CDVA improved significantly in both groups (P<0.001, ANOVA), from first week and during
the entire follow-up (P<0.001, Tukey HSD). There was no significant difference observed in
the mean CDVA between the two groups at each follow-up visit (Table 2). At the last visit, in
Group A, 47 eyes (54%) achieved better CDVA values, 34 eyes (39%) had the same CDVA and
6 eyes (7%) had a poorer CDVA in comparison to preoperative data. In Group B, at the final
follow-up, 49 eyes (52.5%) achieved a better final CDVA values, 37 eyes (40%) had the same
CDVA and 7 (7.5%) patients had a poorer CDVA in comparison to preoperative data. There
was no significant difference observed in the rate of eyes with CDVA improvement between
two groups (P = 0.882, Chi-square test).
Table 1. Demographics and etiology of aphakia for Group A (anterior chamber iris-claw fixation) and Group B (retropupillary iris-claw implantation).
Characteristics Group A Group B P
(n = 87) (n = 93)
Gender, n (%)
Male 49 (56%) 53 (57%) 1.000�
Female 38 (44%) 40 (43%)
Eye, n (%)
Right 47 (54%) 41 (44%) 0.185�
Left 40 (46%) 52 (56%)
Age (Mean ± SD) (years) 70.6 ± 5.5 69.5 ± 6.3 0.215˚
Etiology, n (%)
Spontaneous or traumatic lens/lOL subluxation 6 (7%) 6 (6%) 0.862�
Complicated cataract surgery resulted in aphakia 42 (48%) 47 (51%) 0.888�
Peroperative lens/IOL luxation 33 (38%) 35 (38%) 0.920�
Previous intracapsular cataract extraction 6 (7%) 5 (5%) 0.920�




Table 2. Mean CDVA ± SD (logMAR) of Group A (anterior chamber iris-claw fixation) and Group B (retropupillary iris-claw implantation).
Category Pre-operative Post-operative
1st week 1st month 3rd month 6th month 1st year 3rd year 5th year
Group A (n = 87) 0.37±0.21 0.15±0.21� 0.13±0.19� 0.14±0.23� 0.13±0.22� 0.12±0.16� 0.12±0.11� 0.12±0.15�
Group B (n = 93) 0.41±0.22 0.17±0.23� 0.15±0.21� 0.13±0.15� 0.12±0.14� 0.13±0.13� 0.14±0.13� 0.13±0.15�
P (Unpaired t-test) 0.214 0.544 0.504 0.786 0.712 0.645 0.268 0.655
CDVA = correct distance visual acuity
SD = standard deviation
logMAR = the minimum angle of resolution
ANOVA: both groups P<0.001
�Tukey HSD vs. baseline all measurements: P<0.001
https://doi.org/10.1371/journal.pone.0214140.t002
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IOP
IOP increased significantly among both the groups at 1st week and 1st month (both ANOVA
P<0.001, Tukey HSD P<0.001). A IOP>21 mmHg was noted in 16 patients in Group A and
in 21 patients in Group B at 1st week postoperatively. Patients received a mono-therapy (dor-
zolamide or timolol) if 21< IOP� 25 mmHg, or a dorzolamide/timolol fixed combination
administered twice daily if IOP>25 mmHg; no one had a permanent increase of IOP. There
was no significant difference observed in IOP between the two groups at each follow-up visit
(Table 3).
CECD
CECD did not change in both the groups after surgery (ANOVA, Group A; P = 0.067, Group
B; P = 0.330). The mean difference in CECD before and at 1st week, 1st month and 5th year
after surgery was 92 (4,.9%), 107 (5,.7%) and 219 (11,.6%) cell/mm2 in Group A respectively,
and 110 (5.9%), 135 (7.3%) and 176 (9.5%) cell/mm2 in Group B, respectively. No significant
difference in CEDC was observed between the two groups at each follow-up visit (Table 4).
CCT and CMT
CCT and CMT did not change after surgery in both groups (ANOVA, NS) and there was no
significant difference between two groups at each follow-up visit (paired t-test, NS).
Complications
No intra-operative complications occurred in any of our cases. Postoperative complications
are shown in detail in Table 5. Pigment precipitates were found mainly in Group A (P = 0.009,
Table 3. Comparison of mean IOP ± SD (mmHg) of Group A (anterior chamber iris-claw fixation) and Group B (retropupillary iris-claw implantation).
Category Pre-operative Post-operative
1st week 1st month 3rd month 6th month 1st year 3rd year 5th year
Group A (n = 87) 14.4±2.35 18.7±1.57� 16.1±1.49� 14.9±1.33 14.8±1.22 14.6±1.19 14.7±1.20 14.6±1.18
Group B (n = 93) 14.9±1.42 19.1±1.42� 16.5±1.62� 15.2±1.55 15.1±1.42 14.6±1.30 14.8±1.23 14.7±1.31
P (Unpaired t-test) 0.084 0.074 0.087 0.166 0.131 1 0.582 0.592
IOP = intraocular pressure; SD = standard deviation; mmHg = millimeter of mercury
ANOVA: both group P<0.001
Tukey HSD vs. baseline �P<0.001
https://doi.org/10.1371/journal.pone.0214140.t003
Table 4. Comparison of mean CECD ± SD (cell/mm2) and mean difference in CECD (%) of Group A (anterior chamber iris-claw fixation) and Group B (retropupil-
lary iris-claw implantation).
Category Pre-operative Post-operative
1st week 1st month 3rd month 6th month 1st year 3rd year 5th year
Group A 1872±460 1780±479 1765±463 1735±490 1699±497 1677±487 1684±502 1653±477
-92(4.9) -107(5.7) -137(7.3) -173(9.2) -195(10.4) -188(10) -219(11.6)
Group B 1845±521 1735±462 1710±501 1707±515 1700±508 1694±476 1679±503 1669±493
-110(5.9) -135(7.3) -138(7.5) -145(7.8) -151(8.2) -166(9) -176(9.5)
P (Unpaired t-test) 0.714 0.522 0.446 0.71 0.989 0.813 0.947 0.526
CECD = corneal endothelial cell density; SD = standard deviation; cell/mm2 = number of cells per mm2
https://doi.org/10.1371/journal.pone.0214140.t004
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Chi-square test); the other complications had the same rates in both groups (Chi-square test,
P>0.05). No cases of corneal de-compensation were noted during the follow-up. All the IOLs
were well-centered 1 week postoperatively. Nevertheless, pupillary ovalization was seen in 1
patient in Group A and in 2 patients in Group B; these distortions were ended within a week.
One eye of Group B developed a retinal detachment 3 years after surgery and underwent
25-gauge vitrectomy with gas tamponade. The patient referred a head-trauma occurred five
days before the visit.
Discussion
Our study indicates that both the anterior and posterior Iris IOL implantation is effective in
the treatment of aphakia without sufficient capsule support by improving visual acuity signifi-
cantly without serious intra-operative and postoperative complications at the five-year follow-
up.
There is still no established consensus on the best choice of treatment to correct aphakia
without a sufficient capsule support [1,11]. Nowadays, the major possibilities for secondary
IOL implantation are: transclerally sutured posterior chamber IOLs (PC IOLs) [8], angle-sup-
ported anterior chamber IOLs (AC IOLs) [12], iris-fixated IOLs introduced through the scleral
tunnel [7,13–14] and the flanged IOL fixation technique by Yamane et al. [15]. However, iris-
fixated IOLs are usually preferred by surgeons because they yield an early visual recovery and
better visual outcomes that can be performed less invasively and in a shorter surgical time [9].
They also have a lower incidence of intra-operative and post-operative complications than the
other two IOL types [7, 16–18]. However, there is no evidence available about the best place-
ment method for secondary iris-claw IOL implantation that offers the maximum and earliest
visual recovery over many years and the lowest complication rate [6,19]. Despite a higher inci-
dence of IOL dislocation [11], the retropupillary fixation offers the advantage with physiologi-
cal posterior chamber implantation, resulting in a deeper anterior chamber and a lower intra-
operative and postoperative risk of corneal de-compensation than anterior fixation [11,20,21].
However the published literature on iris-claw IOLs in aphakia is limited with relatively small
numbers of patients with a short follow-up [1,8,17,22–24].
Table 5. Postoperative complications for Group A (anterior chamber iris-claw fixation) and Group B (retropupillary iris-claw implantation).
Complication Group A Group B P� Comments/Management (n˚ of Eyes)
Early (1st week-3rd month)
Wound leak 3 (3,4) 2 (2,1) 0.92 Conservative treatment (3); resuturing (2, one for group)
Hyphema 3 (3,4) 2 (2,1) 0.92 Observation
Pupil ovalization 1 (1,1) 2 (2,1) 1 Observation
IOP elevation 16 (18,4) 21 (22,5) 0.61 Topical medication (37)
Pigment precipitates 26 (29,9) 12 (12,9) 0.009 Topical medication (38)
Hypotony 1 (1,1) 1 (1) 0.507 Wound leak resuturing (2)
CME 1 (1,1) 2 (2,1) 1 Topical medication (3)
Late (1st-5th year)
Elevated IOP 1 (1,1) 1 (1) 0.507 Topical treatment (2)
IOL dislocation 1 (1,1) 2 (2,1) 1 At 1 yr (2, one for group), at 3 yr (1, group B); all repositioned
Pigment precipitates 5 (5,7) 3 (3,2) 0.647 Observation
Retinal tear 0 (0) 1 (1) 1 At 2 yr; laser treatment
Retinal detachment 0 (0) 1 (1) 1 At 3 yr; 25-gauge vitrectomy with gas tamponade
� Chi-square test
https://doi.org/10.1371/journal.pone.0214140.t005
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In this retrospective study, we have compared the long-term efficacy and the rate of compli-
cations for both anterior and posterior Iris IOL implantation to treat aphakia without suffi-
cient capsule support.
Regarding efficacy, in Group A and B the mean CDVA improved significantly from
0.37 ± 0.21 and 0.41 ± 0.22 logMAR preoperatively to 0.15 ± 0.21 and 0.17 ± 0.23 logMAR 1
week after surgery, respectively. After the first month, there was no difference in the postoper-
ative CDVA. In addition, the postoperative CDVA was equal to or better than the preoperative
CDVA in 93% and 92.5% of eyes in Group A and B respectively. Our results are similar to
those of other studies of iris-claw IOLs [1,7,4,9,11,22] and better than those obtained with iris-
sutured PC IOLs, secondary open-loop AC or sulcus-sutured PC IOLs [25–30].
The limitation of iris claw IOL, either anterior iris or posterior iris position, includes the 5.5
large incision and the consequent corneal astigmatism. Baykara et al. preferred a scleral tunnel
incision with a surgical procedure that normally does not require sutures [21]. Peralba et al. in
their retrospective comparative study on iris-claw IOLs reported that creating a wide clear cor-
neal incision could cause a high level of astigmatism if not adequately managed [31].
All the patients included in our study were operated by the same anterior segment surgeon
who performed a superior limbal corneal incision of 5.5 mm. Superior incision is better pro-
tected by the superior eyelid while large temporal incision is more exposed to trauma and
infections. Precautions were taken to obtain a residual astigmatism after suture removal which
was better tolerated. The surgeon who was accustomed to manage the corneal astigmatism was
preferred to suture the limbal corneal wound with three 10–0 nylon sutures and selectively
removed them after 2 months, depending on the patient’s refractive and topographical
astigmatism.
However, de Silva et al. have confirmed that it is difficult to assess the functional outcomes
for each IOL type, reported in the literature, because these lens are often implanted in eyes
with ocular co-morbidities which may themselves limit the final visual outcomes or after com-
plicated cataract surgery, which may itself cause complications [1].
One primary concern about aphakic iris-fixated IOL implantation is the loss of corneal
endothelial cells [7,32,33] and it has been reported to be similar to that of routine cataract
operation [34]. In our study, the mean CECD decreased by 9 to 10% three years after surgery
which is comparable to the results obtained by other studies [8,35]. Anbari and Lake reported
a postoperative decreasing of manual endothelial cell density of about 12% at two-years after
retropupillary iris-claw implantation [36]. According to Gicquel et al., the anterior chamber
implantation causes a higher endothelial cell loss than the retropupillary one [20]. In our series
we had only two cases with an endothelial cell density of<1000 cell/mm2 which received a ret-
ropupillary fixation in both cases. However we preferred to implant IOL retropupillary when
the ECC was less than 1200 cells/mm2. This surgical approach has been also followed by Per-
alba et al. in a recent retrospective case series where authors compared outcomes related to the
two surgical techniques of implantation [31].
The mean difference in CECD before and at 1st week and 1st month after surgery was 92
(4,9%) and 107 (5,7%) cell/mm2 in Group A, and 110 (5.9%) and 135 (7.3%) cell/mm2 in
group B, respectively, suggesting that most endothelial cell damage occurs intra-operatively.
However Qasem et al. reported that endothelial cell loss rate is meaningless at five years fol-
low-up [37], with an increase of 1.6% and 0.5% for Group A and Group B respectively from
3rd to 5th year. Moreover, in our series there was no evidence of corneal de-compensation dur-
ing the entire follow-up in both the groups. Yueqin C et al. [7] suggested that the corneal endo-
thelial cell loss may be mainly because of a mechanical injury due to the contact which occurs
during the surgical procedure between the endothelium and the instruments or the IOL. This
risk can be avoided or limited by protecting the endothelial cells with an adequate amount of
Long-term follow-up of iris-claw IOL implantation
PLOS ONE | https://doi.org/10.1371/journal.pone.0214140 April 10, 2019 8 / 13
viscoelastic material during the surgery. In aphakic iris fixated IOLs, Jonker et al. [38] identi-
fied two main risk factors for endothelial cell loss: a shallow anterior chamber depth and a
smaller distance between the central and peripheral IOL edge to the endothelium. Baykara
et al. [21] suggest that implanting an Artisan aphakic IOL through a scleral tunnel incision
results in a less endothelial damage than through a clear corneal incision. To reduce this risk,
we performed a limbal corneal incision in all cases and iris-claw IOLs were implanted only in
case of aphakic eyes with a deep anterior chamber (>3.2 mm).
As reported previously by Helvaci S. et al. [10], all eyes achieved the desired anatomic
results and no intra-operative complications occurred in any of our cases.
The main postoperative complications reported with Artisan iris-fixated IOLs include: IOP
elevation, glaucoma, pupillary block, pupil ovalization, wound leak, IOL dislocation, hyphema,
retinal detachment, and cystoid macular edema [7,8,35].
Elevated IOP were noted in 16 patients in Group A and in 21 patients in Group B 1st week
post-operatively, without significant difference in IOP means between the two groups during
each follow-up visit. All cases had topical hypotonizing therapy and no prolonged IOP increase
was observed. These results were consistent with the data of Helvaci et al. [10].
Two eyes, one in each group developed a late IOP elevation at 3rd year follow-up visit and
after which a topical therapy was started. Both of these patients had a family history for pri-
mary open angle glaucoma without any inflammation in the anterior chamber or irido-corneal
angle synechiae.
In agreement with de Silva et al. [1], the incidence of lately increased IOP in both groups
was comparable to that which was found after a secondary AC IOL fixation (from 0% to 7%)
[26,39] and lower than the value after a secondary sulcus-sutured (from 0% to 30.7%) [17,27]
or iris-sutured PC IOL fixation (from 5% to 30%) [29]. The complete anterior vitrectomy per-
formed probably prevented a permanent IOP increase in our series. We performed the periph-
eral iridectomies only in Group A and no cases of pupillary block occurred. As suggested by
Forlini et al. this could be explained by the posterior vaulting design of this IOL, when fixed in
a reverse position retropupillary, and the space between the back of the iris and the IOL optic
[2].
A day after surgery in our series, a total of five eyes (3 from Group A and 2 from Group B)
had a wound leak which required a resuturing in two cases (one for each group) for the pres-
ence of hypotony and a shallow chamber. As suggested by de Silva et al. [1], a higher incidence
of wound leak is expected in these cases as a consequence of a 5.5 mm corneal incision in eyes
with previously incised cornea. To ensure sufficient corneal healing, we roughly left corneal
sutures in situ for 2 months before their removal.
Persistent ovalisation of the pupil has been reported from 0% to 13.9% of eyes, especially in
patients who underwent iris reconstruction and more frequently after posterior iris-claw IOL
implantation [2,10,11,21]. In our study, this complication was temporarily (<1 week) observed
in three patients (1 in Group A and 2 in Group B). To avoid this complication, wherever pupil
was minimally distorted, the light diathermy application was performed on the anterior iris tis-
sue for contraction of the tissue.
Another challenge of retropupillary implantation is the probability of IOL dislocation into
the vitreous cavity when enclavation fails, especially after severe trauma [40]. However, these
cases can be often treated by re-enclavation [1]. de Silva et al. reported 6% total incidence of
iris-claw IOL dislocation, occurring from 5 days to 60 months after insertion and often due to
the rigid claws in the earlier generation IOL models [1].
In our series we observed a dislocation rate of 1.6% i.e., 2 cases one for each group of spon-
taneous dislocation at 1st year of follow-up and 1 case occurring after a head-trauma 3 years
after the surgery in Group B. All cases were successfully repositioned. Our rate was comparable
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to the one reported by other studies of posterior-fixated iris-claw IOLs (0% to 10%) [41–43],
and lower than the dislocation rate due to suture breakage in scleral-fixated PC IOL (between
7.8% and 27.9%) [12,44]. It has been suggested that incidence of iris-claw IOL dislocation is
higher in IOLs inserted earlier in the series, suggesting a learning curve [1]. Our lower rate
could be due to well experienced/trained surgeon.
A retinal detachment percentage of 6.3% to 8.2% and a choroidal hemorrhage percentage
of 3.2% after the implantation of a trans-sclerally sutured PC IOL were reported by Vote et al.
[44] and Bading et al. [12]. In agreement with other studies [1,10,23,41,45], we have not
observed any such rate of these complications after both techniques. In our series only a trau-
matic retinal detachment occurred in a patient who had received retropupillary implantation 3
years after the surgery.
Another drawback is the possibility of Artisan IOL damage on the iris [21]. In our study, to
reduce the incidence of pigment precipitates at the end of IOL implantation, we had adminis-
trated a sub-conjunctival corticosteroid [46]. Notwithstanding, we observed various degrees of
pigment precipitates on the surface of the IOL in all eyes 1 day after surgery, that disappeared
after topical corticosteroid treatment. During the last follow-up there was a statistically signifi-
cant difference observed between the two groups, for pigment precipitates (P<0.05, Chi-
square test), which were present in 5 eyes in Group A and in 3 eyes in Group B. As shown pre-
viously [7] in our study no cases of pigment erosion, progressive pigment dispersion or iritis
have been observed.
In our study the total incidence of CME was 1.6% at third month, with a chronic CME inci-
dence of 0%, which is comparable if not better than the rates reported in the literature for each
technique. These rates range from 0% to 33% in case of secondary open-loop AC IOL [26,47],
with higher rates after complicated cataract surgery, from 0% to 7.6% after sulcus-sutured PC
IOLs [17,27], from 0% to 16.7% after iris-sutured PC IOLs [30], and from 5.8% to 33% after
implantation of scleral-fixated PC IOLs [48,49]. Our rate is even lower than the rate (from
4.1% to 4.8%) reported in other studies after retropupillary iris-claw implantation [41,43].
Conclusions
The study suggests that both anterior and retropupillary implantation of Artisan IOL are effective
in visual improvement with a lower rate of complications. In consideration of these results, both
anterior and retropupillary implantation of Artisan IOL are easily applicable surgical procedures.
The choice of surgical procedure depends on the experience of the surgeon. Moreover, further
prospective and randomized studies are required to compare the anterior and posterior implanta-
tion of Artisan IOL with a larger sample group and long-term follow-up with the patients.
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43. Wolter-Roessler M, Küchle M. Correction of aphakia with retroiridally fixated IOL. KlinMonatsblAugen-
heilkd. 2008; 225: 1041–1044.
44. Vote BJ, Tranos P, Bunce C, Charteris DG, Da Cruz L. Long- term outcome of combined pars plana vit-
rectomy and scleral fixated sutured posterior chamber intraocular lens implantation. Am J Ophthalmol.
2006; 141: 308–312. https://doi.org/10.1016/j.ajo.2005.09.012 PMID: 16458685
45. Hara S, Borkenstein AF, Ehmer A, Auffarth GU. Retropupillary fixation of iris-claw intraocular lens ver-
sus transscleral suturing fixation for aphakic eyes without capsular support. J Refract Surg. 2011; 27:
729–735. https://doi.org/10.3928/1081597X-20110623-01 PMID: 21710953
46. Solomon K, Gussler JR, Gussler C, Van Meter WS. Incidence and management of complications of
transsclerally sutured posterior chamber lenses. J Cataract Refract Surg. 1993; 19: 488–493. PMID:
8355155
47. Malinowski SM, Mieler WF, Koenig SB, Han DP, Pulido JS. Combined pars plana vitrectomy-lensect-
omy and open-loop anterior chamber lens implantation. Ophthalmology. 1995; 102: 211–216. PMID:
7862409
48. Uthoff D, Teichmann KD. Secondary implantation of scleral-fixated intraocular lenses. J Cataract
Refract Surg. 1998; 24: 945–950. PMID: 9682115
49. Mittelviefhaus H. A modified technique of transscleral suture fixation of posterior chamber lenses. Oph-
thalmic Surg. 1992; 23: 496–498. PMID: 1407951
Long-term follow-up of iris-claw IOL implantation
PLOS ONE | https://doi.org/10.1371/journal.pone.0214140 April 10, 2019 13 / 13
